Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review highlights the potential of TCM medicinal foods for managing post-COVID disorders and suggests they could provide a safe and efficient long-term therapy due to their milder nature.

In this study, 61.4% of females infected with COVID-19 reported hair problems, such as telogen effluvium and increased gray hair, with most cases starting or worsening post-infection as confirmed by trichoscopy.

In this study, patients with post-COVID syndrome who were admitted to RICU were more likely to develop mood disorders compared to those admitted to ICU.

This study indicates that approximately 18% of discharged COVID-19 patients experience PTSD, highlighting the need for attention to their long-term mental health.

This integrative review concluded that microneedling therapy may be an effective and safe treatment for hair disorders like androgenetic alopecia, alopecia areata, and telogen effluvium, particularly when exacerbated by SARS-CoV-2 infection, offering promising results compared to other therapies.

This study found that female COVID-19 survivors were more likely than males to experience multiple long-term post-COVID symptoms, including fatigue, pain, hair loss, and mood disorders.

This systematic review found that long COVID symptoms, particularly fatigue, sleep disorder, and dyspnoea, were similarly prevalent in ongoing symptomatic COVID-19 and post-COVID-19 syndrome, but psychological issues and poor quality of life were more common in the latter.

Among adults suffering from post-COVID syndrome, this study reported fatigue as the most common long-term effect, observed in 71.4% of cases, followed by shortness of breath, anxiety/depression, and memory and attention deficits.

This multicenter study found that hair and nail disorders, particularly telogen effluvium, commonly developed in patients after severe COVID-19 infection.

This review discusses the various aspects of long COVID, highlighting its multi-organ impact, including symptoms like fatigue and dyspnea, and suggests that vaccination may play a role in prevention and management. Risk factors and potential therapeutic strategies are also examined.

This review found that common post-acute COVID-19 symptoms include fatigue, dyspnea, insomnia, and anxiety, indicating they can persist beyond 60 days after initial infection.

This case report discusses a new onset of alopecia areata following reinfection with COVID-19, suggesting a potential link between COVID-19 infection and this hair loss condition.

This study found that a significant portion of the Beyond-COVID cohort reported persistent symptoms, with Omicron variants showing lower rates and severity of symptoms compared to other variants.

This study found that most patients hospitalized for COVID-19 experienced persistent symptoms over 100 days post-admission, with no significant difference in symptoms between those treated in regular wards and intensive care units.

More symptoms during initial COVID infection increase the risk of long-term effects.

This systematic review reports that for patients with underlying dermatologic disorders who contracted COVID-19, most experienced mild to moderate exacerbation of their skin conditions and were managed similarly to the general population, suggesting treatment discontinuation during acute infection may prevent severe recurrence.

This systematic review found that 5%–10% of COVID-19 cases develop long-term sequelae like neurocognitive impairment and cardiovascular damage, with higher risks in women and severe cases. Vaccination may reduce these risks, but further evidence is needed to confirm its efficacy.

This study found that zinc acetate hydrate may improve fatigue and hair loss symptoms in post-COVID-19 patients.

This systematic review reports that fatigue was the most common symptom in both phases of long COVID, with lung function issues more frequent in the ongoing symptomatic phase and psychological burdens like anxiety and depression more prevalent in the post-COVID syndrome phase.

This review discusses the potential therapeutic role of the edible plant Solanum nigrum for managing COVID-19 symptoms and post-COVID complications based on in silico docking and pharmacological studies, but reports no new clinical results.

This review discusses long-term health impacts and physiological disruptions experienced by COVID-19 survivors, highlighting the potential of nutritional interventions to manage post-acute sequelae and metabolic complications.

This study described cases of alopecia areata occurring after COVID-19 vaccination and highlights management using both topical and systemic therapies.

This review discusses post-acute sequelae of SARS-CoV-2 infection, highlighting the challenges in diagnosing and managing the variety of persistent symptoms, and reports no new clinical results.

COVID-19 vaccination may be linked to alopecia areata, especially in young adults.

This case report describes a post-COVID syndrome patient who experienced symptoms like headache, joint pain, and swollen lymph nodes; treatment with Erbisol drugs reportedly alleviated symptoms and normalized immunological parameters.

This review discusses the development and rapid approval of COVID-19 vaccines and notes the observation of autoimmune disorders, such as alopecia areata, following vaccination; it provides no new clinical results.

This study found that one month after discharge, cardiovascular patients previously hospitalized for COVID-19 experienced reduced respiratory symptoms but increased reports of depression, hypercholesterolemia, fatigue, and sleep disorders.

This study's systematic review found that many individuals recovering from COVID-19 experience high rates of telogen effluvium, a common form of hair loss, highlighting limited epidemiological data and the need for further investigation into this condition post-COVID-19.

The systematic review reports an association between Beau’s lines and COVID-19 infection or vaccination, observing variability in onset and resolution times, and suggesting these nail disorders might indicate previous severe infection or vaccination, as well as potentially signify long COVID-19 syndrome.

In this study, HED patients with COVID-19 showed a higher risk of postinfection fatigue and hair loss compared to controls, suggesting they are more susceptible to long-term consequences of SARS-CoV-2 infection.